Tokunaga T, Nishimura R, Akagi M
Jpn J Surg. 1984 Mar;14(2):122-6. doi: 10.1007/BF02469802.
Muscarinic cholinergic receptor sites in human gastric mucosa were analyzed directly by using radioligand binding techniques with the specific muscarinic antagonist 3H-quinuclidinyl benzilate (QNB) as ligand. Specific binding of 3H-QNB to membrane preparations from human gastric mucosa was saturable, of high affinity (Kd = 4.17 +/- 1.94 nM, Bmax = 0.37 +/- 0.04 pmol/mg protein) and selectively inhibited by muscarinic antagonists (atropine, scopolamine) and agonists (acetylcholine, pilocarpine). These findings provide direct evidence for the existence of muscarinic cholinergic receptors in human gastric mucosa. The specific 3H-QNB binding to its receptor was blocked by atropine but not by histamine, cimetidine, pentagastrin, or synthetic human gastrin. The muscarine and histamine H2-receptor, or muscarine and gastrin receptor, probably do not share the same locus.
采用放射性配体结合技术,以特异性毒蕈碱拮抗剂3H-喹核醇基苯甲酸酯(QNB)作为配体,直接分析了人胃黏膜中的毒蕈碱胆碱能受体位点。3H-QNB与人胃黏膜膜制剂的特异性结合具有饱和性、高亲和力(解离常数Kd = 4.17 +/- 1.94 nM,最大结合容量Bmax = 0.37 +/- 0.04 pmol/mg蛋白质),并被毒蕈碱拮抗剂(阿托品、东莨菪碱)和激动剂(乙酰胆碱、毛果芸香碱)选择性抑制。这些发现为人类胃黏膜中存在毒蕈碱胆碱能受体提供了直接证据。3H-QNB与其受体的特异性结合被阿托品阻断,但未被组胺、西咪替丁、五肽胃泌素或合成人胃泌素阻断。毒蕈碱和组胺H2受体,或毒蕈碱和胃泌素受体,可能不共用同一位点。